Support stronger CPAP therapy adherence with myAir
myAir™ is a simple app that helps patients stay engaged with CPAP therapy through coaching, reminders and nightly sleep data. Among users monitored in AirView,® myAir has been shown to improve compliance from 70% to 87%.1
Air11™ users also gain enhanced support features—Personal Therapy Assistant and Care Check-In—to guide setup, track progress and help patients resolve common therapy challenges.*
Smart Comfort
Smart Comfort is the first FDA-cleared AI-enabled medical device that recommends personalized comfort settings to help people with obstructive sleep apnea (OSA) start and stay on CPAP therapy. For more information read our press release.
2025 myAir Sleep Story is here!
Now in the myAir™ app for a limited time, the 2025 myAir Sleep Story offers a personalized year-end recap that turns your patients’ nightly PAP data into a story highlighting their progress, recognizing their commitment and celebrating how far they’ve come over the past year.
How myAir supports CPAP therapy compliance
Patients using myAir™ are twice as likely to meet CMS 90-day adherence criteria¹, and over 80% remain engaged after one year.2
Data-driven monitoring for healthcare providers
myAir helps patients self-monitor, while AirView® gives providers access to comprehensive therapy data to track progress and support better outcomes.
Data access for better patient monitoring
myAir gives patients a daily score based on key therapy metrics, along with simple dashboards and badges to encourage ongoing use.
Monitoring with AirView
Using myAir with AirView® has been shown to improve compliance by 17%3 compared to AirView alone.
*Some features of myAir are only available in the myAir app and with Air11 devices.
†The myAir by Resmed app is available in English and Spanish in the US. The myAir for Canada by Resmed app is available in English and French in Canada.
**Health trends require patient to allow Apple Health or Health Connect integration. Health metrics may vary by patient based on available data per smart device.
Android, Google Chrome and Google Play are trademarks of Google Inc., registered in the U.S. and other countries. Apple, App Store, iPad, iPhone and Safari are trademarks of Apple Inc., registered in the U.S. or other countries. Microsoft and Microsoft Edge are trademarks of the Microsoft group of companies.
References
- Source: US Medicare adherence criteria: PAP use for ≥ 4 h per night on at least 70% of nights during a consecutive 30-day period during the first 90 days of initial usage
- Source: Drager L et al., “Adherence with positive airway pressure therapy for obstructive sleep apnea in developing versus developed countries: a big data study” (sponsored by Resmed), Journal of Cachexia, Sarcopenia and Muscle, (Nov. 18, 2020), doi: 10.5664/jcsm.9008. n= 4,181,490.
- Source: Malhotra et al, “Patient engagement using new technology to improve adherence to positive airway pressure therapy: A retrospective analysis,” CHEST 153, no. 4 (Apr 2018): 843–850.